A Fully Remote Diagnostic and Treatment Pathway in Patients with Obstructive Sleep Apnoea during the COVID-19 Pandemic: A Single Centre Experience
The COVID-19 pandemic led to significant delays in the diagnostic and management pathway of patients with obstructive sleep apnoea (OSA). During the first wave of COVID-19, our department adopted a fully remote diagnostic (home cardiorespiratory polygraphy) and treatment (autoset continuous positive...
Main Authors: | Andras Bikov, Safia Khalil, Meg Gibbons, Andrew Bentley, David Jones, Saba Bokhari |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/19/4310 |
Similar Items
-
Pathophysiology of obstructive sleep apnoea syndrome: a review
by: Al Riyami B, et al.
Published: (2000-10-01) -
Coagulation and Fibrinolysis in Obstructive Sleep Apnoea
by: Andras Bikov, et al.
Published: (2021-03-01) -
From CPAP to tailored therapy for obstructive sleep Apnoea
by: Kate Sutherland, et al.
Published: (2018-12-01) -
Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia
by: Martina Meszaros, et al.
Published: (2022-10-01) -
OBSTRUCTIVE SLEEP APNOEA IN CHILDREN
by: Nina Božanić Urbančič
Published: (2020-09-01)